The successful event brought together families experiencing rare diseases, researchers, academia and pharmaceutical companies on World Rare Disease Day.
Top story: Silencing of an ALS gene safely delivered to patients in UMass Medical School study
Synthetic microRNA treatment targets mutant SOD1 gene that causes ALS By Jim Fessenden December 24, 2020
As this unprecedented year comes to a close, the Office of Communications is rerunning some of the big stories of 2020 that highlight the incredible work of the UMass Medical School community. From the first-in-the-nation early graduation of our medical students to the essential clinical research that lead to a SARS-CoV-2 vaccine, from the tremendous growth of the institution’s research funding to ground broken on the new research and education building, we have so much to be proud of. Look for these stories on UMassMed News